中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/24402
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 29490/55136 (53%)
造访人次 : 1996982      在线人数 : 511
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于CMUR管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/24402


    题名: 非瑟素動力學及黃酮類化合物對於環孢靈動力學影響之構效關係;Pharmacokinetics of Fisetin and Structure-Activity Relationship for the Effect of Flavonoids on the Cyclosporine Pharmacokinetics
    作者: 夏麒盛;CHI-SHENG SHIA
    贡献者: 中國醫藥學院藥物化學研究所
    关键词: 非瑟素;黃酮類;藥物動力學;環孢靈;交互作用;構效關係;Fisetin;flavonoid;pharmacokinetics;pharmacokinetics;interaction
    日期: 1992
    上传时间: 2009-12-23
    摘要: 非瑟素(Fisetin)為一具許多優越活性之天然黃酮類化合物,本研究以大白鼠為模型,探討非瑟素靜脈注射及口服給藥後之動力學行為。血清中非瑟素代謝物之定量,係將檢品於37℃下以β-glucuronidase水解6小時或以sulfatase水解4小時後,利用高效液相層析法定量。非瑟素靜脈注射給藥後,非瑟素sulfates之平均血藥面積為glucuronides之4.6倍,而原形藥僅為glucuronides之三分之一,顯示非瑟素靜脈注射給藥後主要係以sulfates結合態代謝物存在於全身循環中。 非瑟素口服給藥後吸收迅速,原形藥平均Tmax為5分鐘,絕對生可用率為44.1 %。非瑟素sulfates之平均血峰濃度為glucuronides之2.6倍,平均血藥面積為glucuronides之2.2倍,顯示非瑟素口服給藥後主要亦以sulfates之結合態代謝物形式存在於體內。本研究結果顯示,此類結合態代謝物於體內發揮藥理作用之重要性不可忽略。 環孢靈為一強效免疫抑制劑,治療指數極小,任何改變環孢靈吸收之因素,皆可能危及患者之生命安全。本研究以特定結構之黃酮類化合物5-hydroxyflavone、flavone、quercetin、fisetin及morin,探討其對於環孢靈動力學之影響,並探討其構效關係。結果顯示,各黃酮類化合物與環孢靈併用後,導致增加或降低環孢靈吸收之作用。於40 mg/kg或50 mg/kg劑量時,黃酮類結構中A環第五位之酚基存在與否,不影響其與環孢靈之交互作用,B環上3''與4''鄰位酚基較2''與4''間位酚基,更明顯降低環孢靈之吸收。於20 mg/kg劑量時,A環第五位酚基明顯增強對環孢靈吸收增加之影響,B環上2''與4''間位酚基顯著增加環孢靈之吸收,而3''與4''鄰位酚基反而顯著降低環孢靈之吸收。 本研究利用體外翻腸試驗,探討5-hydroxyflavone、flavone及morin等黃酮類化合物影響環孢靈生可用率之機轉,是否與影響腸內Pgp之活性有關。實驗結果顯示,對腸道Pgp的作用無法解釋5-hydroxyflavone、flavone降低環孢靈吸收之現象,推測可能尚有其他機轉。影響環孢靈吸收之體內機制極為複雜,尚待更進一步研究以釐清交互作用之主要機轉。吾人建議為確保環孢靈之療效與安全,器官移植患者應避免併服富含黃酮類之中草藥或保健食品。; Fisetin is a bioactive natural flavonoid. In this study, the pharmacokinetics of fisetin was investigated in rats. The serum concentrations of fisetin were assayed by HPLC method after incubation at 37℃ for 6 hours with glucuronidase or 4 hours with sulfatase. After intravenous administration of fisetin, the AUC of fisetin sulfates was 4.6-fold glucuronides, whereas the parent form only one-third of glucuronides, suggesting that the major molecules circulating in blood were fisetin sulfates. When fisetin was administered orally, Tmax of the parent form was 5 minutes, indicating that fisetin was absorbed rapidly. The absolute bioavailability of fisetin was 44.1 %, and the major molecules circulating in bloodstream were fisetin sulfates. The Cmax of fisetin sulfates was 2.6-fold of glucuronides, and the AUC was 2.2-fold of glucuronides. It is suggested that sulfates of fisetin be more focused than fisetin for in vitro pharmacological studies in order to have a more accurate model for in vivo systems. Cyclosporine is a widely used immunosuppressant with a narrow therapeutic window. Any factor affecting the absorption or disposition of cyclosporine is therefore of therapeutic importance. The present study attempted to measure the influence of coadministration of flavonoids including 5-hydroxyflavone, flavone, quercetin, fisetin and morin on the pharmacokinetics of cyclosporine in rats, and the structure-activity relationship was explored. Our results showed that each flavonoid investigated resulted in alteration of cyclosporine pharmacokinetics. The structure-activity relationship was established. At dose of 40 mg/kg or 50 mg/kg, the presence of 5-OH didn’t affect the interaction with cyclosporine, the presence of 3'',4''-dihydroxy groups significantly decreased cyclosporine bioavailability in greater extent than 2'',4''-dihydroxy groups. At dose of 20 mg/kg, the presence of 5-OH significantly reinforced the increase of cyclosporine bioavailability, the presence of 2'',4''-dihydroxy groups significantly increased cyclosporine bioavailability, whereas the presence of 3'',4''-dihydroxy groups significantly decreased that. A study using the everted intestinal sac was carried out to dissect the mechanisms of flavonoids-cyclosporine interaction. Our results showed that the in vitro evidence could not explain the in vivo effects of 5-hydroxyflavone and flavone on the fate of cyclosporine. It was conjectured that there were other mechanisms involved. It is suggested that concurrent use of flavonoids-containing herbs or dietary supplements with cyclosporine or other CYP3A4/P-gp substrates should be avoid.
    显示于类别:[藥物化學研究所] 博碩士論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    reference3.pdf53KbAdobe PDF383检视/开启
    全圖-1.pdf91KbAdobe PDF503检视/开启
    全表-0-720.pdf115KbAdobe PDF715检视/开启
    摘要.pdf30KbAdobe PDF652检视/开启
    目錄.pdf21KbAdobe PDF556检视/开启
    第一章 緒言3.pdf24KbAdobe PDF754检视/开启
    第三章 實驗部分2.pdf53KbAdobe PDF1016检视/开启
    第二章 總論2.pdf145KbAdobe PDF1044检视/开启
    第四章 結果與討論2.pdf57KbAdobe PDF723检视/开启
    論文題目.pdf20KbAdobe PDF552检视/开启
    造字.pdf19KbAdobe PDF347检视/开启
    附 錄.pdf25KbAdobe PDF689检视/开启
    附圖、附表目錄.pdf61KbAdobe PDF410检视/开启


    在CMUR中所有的数据项都受到原著作权保护.

    TAIR相关文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈